{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T06:16:01Z","timestamp":1783836961539,"version":"3.55.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015624","name":"University of Jeddah","doi-asserted-by":"crossref","award":["UJ-23-DR-183"],"award-info":[{"award-number":["UJ-23-DR-183"]}],"id":[{"id":"10.13039\/501100015624","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100015624","name":"University of Jeddah","doi-asserted-by":"crossref","award":["UJ-23-DR-183"],"award-info":[{"award-number":["UJ-23-DR-183"]}],"id":[{"id":"10.13039\/501100015624","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100015624","name":"University of Jeddah","doi-asserted-by":"crossref","award":["UJ-23-DR-183"],"award-info":[{"award-number":["UJ-23-DR-183"]}],"id":[{"id":"10.13039\/501100015624","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100015624","name":"University of Jeddah","doi-asserted-by":"crossref","award":["UJ-23-DR-183"],"award-info":[{"award-number":["UJ-23-DR-183"]}],"id":[{"id":"10.13039\/501100015624","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100015624","name":"University of Jeddah","doi-asserted-by":"crossref","award":["UJ-23-DR-183"],"award-info":[{"award-number":["UJ-23-DR-183"]}],"id":[{"id":"10.13039\/501100015624","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100015624","name":"University of Jeddah","doi-asserted-by":"crossref","award":["UJ-23-DR-183"],"award-info":[{"award-number":["UJ-23-DR-183"]}],"id":[{"id":"10.13039\/501100015624","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>In the current study, triazolo pyrimidine coumarin and benzocoumarin derivatives were prepared using green methods as a fast and cost-efficient strategy in comparison with the traditional method in terms of reaction time and yield. Combining coumarins with other bioactive compounds could improve the anticancer properties and other biological activities. Therefore, both compounds were evaluated in silico as potential early-stage small molecule inhibitors of three targets, which cause four life-threatening diseases: leukaemia FLT3 (PDB: 4XUF), SARS-COV-2 (3CLpro) (PDB: 6M2N), and adenosine A1 receptors A1R (PDB: 5N2S), which could cause heart failure and Alzheimer\u2019s disease. It was discovered that both compounds show promising results against the three targets. However, benzocoumarin shows an advantage over coumarin compounds. The effects of modifications to the coumarin core have been studied using an in silico technique that evaluates pharmacokinetics, absorption, distribution, metabolism, excretion, and toxicity of these compounds, showing promising results as an early-stage drug. However, both compounds were predicted to be highly absorbed from the gastrointestinal tract and enter the blood-brain barrier efficiently. The predicted oral toxicity of both compounds was LD50\u2009=\u2009350\u00a0mg\/kg, putting both of them in the IV toxicity class. The optical properties of coumarin and benzocoumarin compounds were also investigated.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1186\/s13065-025-01636-6","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T08:44:30Z","timestamp":1760431470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Triazolo pyrimidine derivatives of coumarin and benzocoumarin: green synthesis, biological activity screening study with in silico evaluation"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7713-8137","authenticated-orcid":false,"given":"Hawazen M.","family":"Hassanain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaad J.","family":"Al-Zahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roaa M.","family":"Alreemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9475-0598","authenticated-orcid":false,"given":"Huda A.","family":"Al-Ghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahlam I.","family":"Al-Sulami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3131-2301","authenticated-orcid":false,"given":"Khadijah M.","family":"Al-Zaydi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"37","key":"1636_CR1","doi-asserted-by":"publisher","first-page":"23963","DOI":"10.1039\/D2RA03774B","volume":"12","author":"M Uroos","year":"2022","unstructured":"Uroos M, et al. Green synthesis of coumarin derivatives using Br\u00f8nsted acidic pyridinium based ionic liquid [MBSPy][HSO 4] to control an opportunistic human and a devastating plant pathogenic fungus macrophomina Phaseolina. RSC Adv. 2022;12(37):23963\u201372.","journal-title":"RSC Adv"},{"issue":"6","key":"1636_CR2","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1016\/j.ejmech.2010.02.048","volume":"45","author":"RS Keri","year":"2010","unstructured":"Keri RS, et al. Analgesic, anti-pyretic and DNA cleavage studies of novel pyrimidine derivatives of coumarin moiety. Eur J Med Chem. 2010;45(6):2597\u2013605.","journal-title":"Eur J Med Chem"},{"issue":"22","key":"1636_CR3","doi-asserted-by":"publisher","first-page":"6504","DOI":"10.1016\/j.bmcl.2010.09.055","volume":"20","author":"KV Sashidhara","year":"2010","unstructured":"Sashidhara KV, et al. Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives. Bioorg Med Chem Lett. 2010;20(22):6504\u20137.","journal-title":"Bioorg Med Chem Lett"},{"key":"1636_CR4","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s11164-018-03722-y","volume":"45","author":"M Khaleghi-Abbasabadi","year":"2019","unstructured":"Khaleghi-Abbasabadi M, Azarifar D. Magnetic Fe 3 O 4-supported sulfonic acid-functionalized graphene oxide (Fe 3 O 4@ GO-naphthalene-SO 3 H): a novel and recyclable nanocatalyst for green one-pot synthesis of 5-oxo-dihydropyrano [3, 2-c] Chromenes and 2-amino-3-cyano-1, 4, 5, 6-tetrahydropyrano [3, 2-c] quinolin-5-ones. Res Chem Intermed. 2019;45:2095\u2013118.","journal-title":"Res Chem Intermed"},{"issue":"11","key":"1636_CR5","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1002\/jccs.201200010","volume":"59","author":"X Ni","year":"2012","unstructured":"Ni X, et al. Effect of structure and conformation on fluorescence properties in novel Coumarin-based Mannich base dyes. J Chin Chem Soc. 2012;59(11):1439\u201345.","journal-title":"J Chin Chem Soc"},{"issue":"2","key":"1636_CR6","first-page":"1","volume":"382","author":"D Gupta","year":"2024","unstructured":"Gupta D, Guliani E, Bajaj K. Coumarin\u2014Synthetic Methodologies, Pharmacology, and application as natural fluorophore. Top Curr Chem. 2024;382(2):1\u201338.","journal-title":"Top Curr Chem"},{"issue":"7","key":"1636_CR7","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/cancers12071959","volume":"12","author":"E K\u00fcpeli Akkol","year":"2020","unstructured":"K\u00fcpeli Akkol E, et al. Coumarins and coumarin-related compounds in pharmacotherapy of cancer. Cancers. 2020;12(7):1959.","journal-title":"Cancers"},{"issue":"1","key":"1636_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/17518253.2018.1556743","volume":"12","author":"A Abdel-Aziem","year":"2019","unstructured":"Abdel-Aziem A, et al. Synthesis and cytotoxic activity of some novel benzocoumarin derivatives under solvent free conditions. Green Chem Lett Rev. 2019;12(1):9\u201318.","journal-title":"Green Chem Lett Rev"},{"key":"1636_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejmech.2016.03.087","volume":"119","author":"J Dandriyal","year":"2016","unstructured":"Dandriyal J, et al. Recent developments of C-4 substituted coumarin derivatives as anticancer agents. Eur J Med Chem. 2016;119:141\u201368.","journal-title":"Eur J Med Chem"},{"issue":"2","key":"1636_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/molecules21020249","volume":"21","author":"MAI Salem","year":"2016","unstructured":"Salem MAI, Marzouk MI, El-Kazak AM. Synthesis and characterization of some new coumarins with in vitro antitumor and antioxidant activity and high protective effects against DNA damage. Molecules. 2016;21(2):249.","journal-title":"Molecules"},{"issue":"10","key":"1636_CR11","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/ajoc.201402107","volume":"3","author":"D Kim","year":"2014","unstructured":"Kim D, et al. Synthesis of benzocoumarins and characterization of their photophysical properties. Asian J Org Chem. 2014;3(10):1089\u201396.","journal-title":"Asian J Org Chem"},{"issue":"7","key":"1636_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2174\/1389557514666140622204608","volume":"14","author":"H-N Lv","year":"2014","unstructured":"Lv H-N, Tu P-F, Jiang Y. Benzocoumarins: isolation, synthesis, and biological activities. Mini Rev Med Chem. 2014;14(7):603\u201322.","journal-title":"Mini Rev Med Chem"},{"issue":"12","key":"1636_CR13","doi-asserted-by":"publisher","first-page":"21826","DOI":"10.3390\/molecules201219803","volume":"20","author":"SM Gomha","year":"2015","unstructured":"Gomha SM, Zaki YH, Abdelhamid AO. Utility of 3-Acetyl-6-bromo-2 H-chromen-2-one for the synthesis of new heterocycles as potential antiproliferative agents. Molecules. 2015;20(12):21826\u201339.","journal-title":"Molecules"},{"key":"1636_CR14","doi-asserted-by":"crossref","unstructured":"Chandrakanth M et al. Coumarin\u20131, 2, 4-Triazole hybrids: recent advances in synthesis and medicinal applications. J Mol Struct, 2023: p. 137197.","DOI":"10.1016\/j.molstruc.2023.137197"},{"key":"1636_CR15","doi-asserted-by":"publisher","first-page":"134487","DOI":"10.1016\/j.molstruc.2022.134487","volume":"1274","author":"O Gupta","year":"2023","unstructured":"Gupta O, Pradhan T, Chawla G. An updated review on diverse range of biological activities of 1, 2, 4-triazole derivatives: insight into structure activity relationship. J Mol Struct. 2023;1274:134487.","journal-title":"J Mol Struct"},{"issue":"10","key":"1636_CR16","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s00044-020-02609-1","volume":"29","author":"S Pinheiro","year":"2020","unstructured":"Pinheiro S, et al. Biological activities of [1, 2, 4] Triazolo [1, 5-a] pyrimidines and analogs. Med Chem Res. 2020;29(10):1751\u201376.","journal-title":"Med Chem Res"},{"key":"1636_CR17","doi-asserted-by":"crossref","unstructured":"Kolukula GBNVN, et al. Exploring the antimicrobial potential of novel 1, 2, 4\u2009\u2013\u2009Triazole conjugates with pyrazole: Synthesis, biological activity and in Silico Docking. Volume 22. Chemistry & Biodiversity; 2025. p. e202401810. 1.","DOI":"10.1002\/cbdv.202401810"},{"key":"1636_CR18","doi-asserted-by":"publisher","first-page":"141850","DOI":"10.1016\/j.molstruc.2025.141850","volume":"1334","author":"AB Reddy","year":"2025","unstructured":"Reddy AB, et al. New quinazolinone-1, 2, 4-triazole analogues: Synthesis, anticancer evaluation, molecular docking, and in Silico ADMET prediction. J Mol Struct. 2025;1334:141850.","journal-title":"J Mol Struct"},{"key":"1636_CR19","doi-asserted-by":"crossref","unstructured":"Rao Gollapalli V, et al. New Fluoroquinolone-1, 2, 4\u2010triazoles as potent antibacterial agents: Design, Synthesis, Docking studies and in Silico ADME profiles. Volume 20. Chemistry & Biodiversity; 2023. p. e202201259. 4.","DOI":"10.1002\/cbdv.202201259"},{"key":"1636_CR20","doi-asserted-by":"crossref","unstructured":"ElkAnzI NALIA. Synthesis and biological activities of some pyrimidine derivatives:(A-Review). Orient J Chem, 2020. 36(6).","DOI":"10.13005\/ojc\/360602"},{"issue":"17","key":"1636_CR21","doi-asserted-by":"publisher","first-page":"e202501012","DOI":"10.1002\/slct.202501012","volume":"10","author":"S Choppadandi","year":"2025","unstructured":"Choppadandi S, et al. Design, Synthesis, and antibacterial evaluation of pyrazole pyrimidine hybrids: integrative in vitro and in Silico studies. ChemistrySelect. 2025;10(17):e202501012.","journal-title":"ChemistrySelect"},{"issue":"1","key":"1636_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1515\/chem-2021-0024","volume":"19","author":"MH Abdellatiif","year":"2021","unstructured":"Abdellatiif MH, et al. Computational studies by molecular Docking of some antiviral drugs with COVID-19 receptors are an approach to medication for COVID-19. Open Chem. 2021;19(1):245\u201364.","journal-title":"Open Chem"},{"issue":"1","key":"1636_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13721-019-0207-3","volume":"9","author":"MA Hussien","year":"2020","unstructured":"Hussien MA, Abdelaziz AEM. Molecular Docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease. Netw Model Anal Health Inf Bioinf. 2020;9(1):1\u201318.","journal-title":"Netw Model Anal Health Inf Bioinf"},{"issue":"14","key":"1636_CR24","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2217\/fon-2019-0670","volume":"16","author":"K Saleh","year":"2020","unstructured":"Saleh K, Khalifeh-Saleh N, Kourie HR. Acute myeloid leukemia transformed to a targetable disease. Future Oncol. 2020;16(14):961\u201372.","journal-title":"Future Oncol"},{"key":"1636_CR25","doi-asserted-by":"publisher","first-page":"1204895","DOI":"10.3389\/fonc.2023.1204895","volume":"13","author":"K Barbosa","year":"2023","unstructured":"Barbosa K, Deshpande AJ. Therapeutic targeting of leukemia stem cells in acute myeloid leukemia. Front Oncol. 2023;13:1204895.","journal-title":"Front Oncol"},{"issue":"3","key":"1636_CR26","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1152\/physrev.00029.2018","volume":"99","author":"JU Kazi","year":"2019","unstructured":"Kazi JU, R\u00f6nnstrand L. FMS-like tyrosine kinase 3\/FLT3: from basic science to clinical implications. Physiol Rev. 2019;99(3):1433\u201366.","journal-title":"Physiol Rev"},{"key":"1636_CR27","doi-asserted-by":"crossref","unstructured":"Grafone T et al. An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment. Oncol Reviews, 2012. 6(1).","DOI":"10.4081\/oncol.2012.e8"},{"issue":"6","key":"1636_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/10408363.2020.1783198","volume":"57","author":"M Ciotti","year":"2020","unstructured":"Ciotti M, et al. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 2020;57(6):365\u201388.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"13","key":"1636_CR29","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1056\/NEJMp2002125","volume":"382","author":"M Lipsitch","year":"2020","unstructured":"Lipsitch M, Swerdlow DL, Finelli L. Defining the epidemiology of Covid-19\u2014studies needed. N Engl J Med. 2020;382(13):1194\u20136.","journal-title":"N Engl J Med"},{"issue":"5","key":"1636_CR30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","volume":"20","author":"MM Lamers","year":"2022","unstructured":"Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022;20(5):270\u201384.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"1636_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41421-020-0153-3","volume":"6","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, et al. Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2. Cell Discovery. 2020;6(1):1\u201318.","journal-title":"Cell Discovery"},{"key":"1636_CR32","doi-asserted-by":"publisher","first-page":"1374364","DOI":"10.3389\/fmolb.2024.1374364","volume":"11","author":"JL Vald\u00e9s-Albuernes","year":"2024","unstructured":"Vald\u00e9s-Albuernes JL, et al. Modeling of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-2 considering the protein flexibility by using molecular dynamics and cross-docking. Front Mol Biosci. 2024;11:1374364.","journal-title":"Front Mol Biosci"},{"key":"1636_CR33","doi-asserted-by":"publisher","first-page":"819165","DOI":"10.3389\/fchem.2021.819165","volume":"9","author":"Z Lv","year":"2022","unstructured":"Lv Z, et al. Targeting SARS-CoV-2 proteases for COVID-19 antiviral development. Front Chem. 2022;9:819165.","journal-title":"Front Chem"},{"issue":"1","key":"1636_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1039\/D2MD00344A","volume":"14","author":"R Chen","year":"2023","unstructured":"Chen R, et al. Advances in research on 3\u00a0C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020. RSC Med Chem. 2023;14(1):9\u201321.","journal-title":"RSC Med Chem"},{"issue":"6","key":"1636_CR35","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s12551-022-01020-x","volume":"14","author":"A Kidera","year":"2022","unstructured":"Kidera A, et al. Functional dynamics of SARS-CoV-2 3\u00a0C-like protease as a member of clan PA. Biophys Rev. 2022;14(6):1473\u201385.","journal-title":"Biophys Rev"},{"issue":"2","key":"1636_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1021\/acscentsci.2c01359","volume":"9","author":"N Hou","year":"2023","unstructured":"Hou N, et al. Development of highly potent noncovalent inhibitors of SARS-CoV-2 3CLpro. ACS Cent Sci. 2023;9(2):217\u201327.","journal-title":"ACS Cent Sci"},{"key":"1636_CR37","doi-asserted-by":"publisher","first-page":"876212","DOI":"10.3389\/fchem.2022.876212","volume":"10","author":"DJ Calleja","year":"2022","unstructured":"Calleja DJ, Lessene G, Komander D. Inhibitors of sars-cov-2 Plpro. Front Chem. 2022;10:876212.","journal-title":"Front Chem"},{"issue":"4","key":"1636_CR38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","volume":"10","author":"MT ul Qamar","year":"2020","unstructured":"ul Qamar MT, et al. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. 2020;10(4):313\u20139.","journal-title":"J Pharm Anal"},{"issue":"3","key":"1636_CR39","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.drudis.2020.12.005","volume":"26","author":"R Banerjee","year":"2021","unstructured":"Banerjee R, Perera L, Tillekeratne LMV. Potential SARS-CoV-2 main protease inhibitors. Drug Discovery Today. 2021;26(3):804\u201316.","journal-title":"Drug Discovery Today"},{"issue":"6575","key":"1636_CR40","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","volume":"374","author":"DR Owen","year":"2021","unstructured":"Owen DR, et al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science. 2021;374(6575):1586\u201393.","journal-title":"Science"},{"issue":"9","key":"1636_CR41","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.1021\/acs.jmedchem.2c00117","volume":"65","author":"Y Unoh","year":"2022","unstructured":"Unoh Y, et al. Discovery of S-217622, a noncovalent oral SARS-CoV-2 3CL protease inhibitor clinical candidate for treating COVID-19. J Med Chem. 2022;65(9):6499\u2013512.","journal-title":"J Med Chem"},{"key":"1636_CR42","doi-asserted-by":"publisher","first-page":"622898","DOI":"10.3389\/fchem.2021.622898","volume":"9","author":"HM Mengist","year":"2021","unstructured":"Mengist HM, Dilnessa T, Jin T. Structural basis of potential inhibitors targeting SARS-CoV-2 main protease. Front Chem. 2021;9:622898.","journal-title":"Front Chem"},{"key":"1636_CR43","first-page":"57206","volume":"10","author":"R da Lapa","year":"2014","unstructured":"da Lapa R. Pharmacology of adenosine receptors and their signaling role in immunity and inflammation. Pharmacol Ther. 2014;10:57206.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"1636_CR44","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","volume":"98","author":"PA Borea","year":"2018","unstructured":"Borea PA, et al. Pharmacology of adenosine receptors: the state of the Art. Physiol Rev. 2018;98(3):1591\u2013625.","journal-title":"Physiol Rev"},{"issue":"3","key":"1636_CR45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/CRD.0b013e31819f1a98","volume":"17","author":"RH Shah","year":"2009","unstructured":"Shah RH, Frishman WH. Adenosine1 receptor antagonism: a new therapeutic approach for the treatment of decompensated heart failure. Cardiol Rev. 2009;17(3):125\u201331.","journal-title":"Cardiol Rev"},{"issue":"3","key":"1636_CR46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11302-022-09883-1","volume":"18","author":"PNH Trinh","year":"2022","unstructured":"Trinh PNH, et al. Adenosine receptor signalling in alzheimer\u2019s disease. Purinergic Signalling. 2022;18(3):359\u201381.","journal-title":"Purinergic Signalling"},{"key":"1636_CR47","doi-asserted-by":"crossref","unstructured":"Fonseca A, et al. Coumarins and adenosine receptors: new perceptions in structure\u2013affinity relationships. Volume 91. Chemical Biology & Drug Design; 2018. pp. 245\u201356. 1.","DOI":"10.1111\/cbdd.13075"},{"issue":"18","key":"1636_CR48","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.3390\/molecules25184306","volume":"25","author":"S Vazquez-Rodriguez","year":"2020","unstructured":"Vazquez-Rodriguez S, et al. Adenosine receptor ligands: Coumarin\u2013Chalcone hybrids as modulating agents on the activity of h ARs. Molecules. 2020;25(18):4306.","journal-title":"Molecules"},{"issue":"4","key":"1636_CR49","doi-asserted-by":"publisher","first-page":"e0121177","DOI":"10.1371\/journal.pone.0121177","volume":"10","author":"JA Zorn","year":"2015","unstructured":"Zorn JA, et al. Crystal structure of the FLT3 kinase domain bound to the inhibitor Quizartinib (AC220). PLoS ONE. 2015;10(4):e0121177.","journal-title":"PLoS ONE"},{"issue":"9","key":"1636_CR50","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","volume":"41","author":"H-x Su","year":"2020","unstructured":"Su H-x, et al. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacol Sin. 2020;41(9):1167\u201377.","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"1636_CR51","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.str.2017.06.012","volume":"25","author":"RKY Cheng","year":"2017","unstructured":"Cheng RKY, et al. Structures of human A1 and A2A adenosine receptors with Xanthines reveal determinants of selectivity. Structure. 2017;25(8):1275\u201385.","journal-title":"Structure"},{"issue":"10","key":"1636_CR52","doi-asserted-by":"publisher","first-page":"457","DOI":"10.6026\/97320630008457","volume":"8","author":"P Sivamani","year":"2012","unstructured":"Sivamani P, et al. Comparative molecular Docking analysis of essential oil constituents as elastase inhibitors. Bioinformation. 2012;8(10):457.","journal-title":"Bioinformation"},{"key":"1636_CR53","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3389\/fchem.2020.595097","volume":"8","author":"O Ya\u00f1ez","year":"2021","unstructured":"Ya\u00f1ez O, et al. In Silico study of coumarins and Quinolines derivatives as potent inhibitors of SARS-CoV-2 main protease. Front Chem. 2021;8:1273.","journal-title":"Front Chem"},{"issue":"1","key":"1636_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):1\u201313.","journal-title":"Sci Rep"},{"issue":"W1","key":"1636_CR55","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee P, et al. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46(W1):W257\u201363.","journal-title":"Nucleic Acids Res"},{"key":"1636_CR56","doi-asserted-by":"publisher","first-page":"W53","DOI":"10.1093\/nar\/gku401","volume":"42","author":"MN Drwal","year":"2014","unstructured":"Drwal MN, et al. ProTox: a web server for the in Silico prediction of rodent oral toxicity. Nucleic Acids Res. 2014;42:W53.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1636_CR57","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jsps.2020.03.010","volume":"28","author":"D MacLeod-Carey","year":"2020","unstructured":"MacLeod-Carey D, et al. Evaluation of new antihypertensive drugs designed in Silico using thermolysin as a target. Saudi Pharm J. 2020;28(5):582\u201392.","journal-title":"Saudi Pharm J"},{"issue":"7","key":"1636_CR58","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/80700541","volume":"8","author":"KM Al-Zaydi","year":"2003","unstructured":"Al-Zaydi KM. Microwave assisted synthesis, part 1: rapid solventless synthesis of 3-substituted coumarins and benzocoumarins by microwave irradiation of the corresponding enaminones. Molecules. 2003;8(7):541\u201355.","journal-title":"Molecules"},{"key":"1636_CR59","doi-asserted-by":"crossref","unstructured":"Varma RS. Greener and sustainable trends in synthesis of organics and nanomaterials. ACS; 2016.","DOI":"10.1021\/acssuschemeng.6b01623"},{"issue":"4","key":"1636_CR60","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/jhet.5570380428","volume":"38","author":"FMAA El-Taweel","year":"2001","unstructured":"El-Taweel FMAA, Elnagdi MH. Studies with enaminones: synthesis of new coumarin\u20103\u2010yl azoles, coumarin\u20103\u2010yl azines, coumarin\u20103\u2010yl azoloazines, coumarin\u20103\u2010yl pyrone and coumarin\u20102\u2010yl benzo [b] furans. J Heterocycl Chem. 2001;38(4):981\u20134.","journal-title":"J Heterocycl Chem"},{"issue":"11","key":"1636_CR61","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrd1549","volume":"3","author":"DB Kitchen","year":"2004","unstructured":"Kitchen DB, et al. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discovery. 2004;3(11):935\u201349.","journal-title":"Nat Rev Drug Discovery"},{"issue":"3","key":"1636_CR62","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0959-440X(96)80061-3","volume":"6","author":"T Lengauer","year":"1996","unstructured":"Lengauer T, Rarey M. Computational methods for biomolecular Docking. Curr Opin Struct Biol. 1996;6(3):402\u20136.","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"1636_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0974-777X.176140","volume":"8","author":"V Sikka","year":"2016","unstructured":"Sikka V, et al. The emergence of Zika virus as a global health security threat: a review and a consensus statement of the INDUSEM joint working group (JWG). J Global Infect Dis. 2016;8(1):3.","journal-title":"J Global Infect Dis"},{"issue":"1","key":"1636_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-13940-6","volume":"11","author":"TP Sheahan","year":"2020","unstructured":"Sheahan TP, et al. Comparative therapeutic efficacy of Remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020;11(1):1\u201314.","journal-title":"Nat Commun"},{"key":"1636_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev. 2001;46:3.","journal-title":"Adv Drug Delivery Rev"},{"issue":"12","key":"1636_CR66","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, et al. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45(12):2615\u201323.","journal-title":"J Med Chem"},{"issue":"1","key":"1636_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","volume":"1","author":"AK Ghose","year":"1999","unstructured":"Ghose AK, Viswanadhan VN, Wendoloski JJ. A Knowledge-Based approach in designing combinatorial or medicinal chemistry libraries for drug Discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem. 1999;1(1):55\u201368.","journal-title":"J Comb Chem"},{"issue":"21","key":"1636_CR68","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1021\/jm000292e","volume":"43","author":"WJ Egan","year":"2000","unstructured":"Egan WJ, Merz KM, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem. 2000;43(21):3867\u201377.","journal-title":"J Med Chem"},{"issue":"12","key":"1636_CR69","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/jm015507e","volume":"44","author":"I Muegge","year":"2001","unstructured":"Muegge I, Heald SL, Brittelli D. Simple selection criteria for Drug-like chemical matter. J Med Chem. 2001;44(12):1841\u20136.","journal-title":"J Med Chem"},{"issue":"20","key":"1636_CR70","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1021\/jm000942e","volume":"43","author":"P Ertl","year":"2000","unstructured":"Ertl P, Rohde B, Selzer P. Fast calculation of molecular Polar surface area as a sum of Fragment-Based contributions and its application to the prediction of drug transport properties. J Med Chem. 2000;43(20):3714\u20137.","journal-title":"J Med Chem"},{"issue":"11","key":"1636_CR71","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1021\/ja00193a003","volume":"111","author":"N Bodor","year":"1989","unstructured":"Bodor N, Gabanyi Z, Wong CK. A new method for the Estimation of partition coefficient. J Am Chem Soc. 1989;111(11):3783\u20136.","journal-title":"J Am Chem Soc"},{"key":"1636_CR72","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1023\/A:1008060415622","volume":"12","author":"R Mannhold","year":"1998","unstructured":"Mannhold R, et al. Multivariate analysis of experimental and computational descriptors of molecular lipophilicity. J Comput Aided Mol Des. 1998;12:573\u201381.","journal-title":"J Comput Aided Mol Des"},{"issue":"11","key":"1636_CR73","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"A Daina","year":"2016","unstructured":"Daina A, Zoete V. A boiled-egg to predict Gastrointestinal absorption and brain penetration of small molecules. ChemMedChem. 2016;11(11):1117.","journal-title":"ChemMedChem"},{"issue":"2","key":"1636_CR74","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S1359-6446(01)02100-6","volume":"7","author":"HE Selick","year":"2002","unstructured":"Selick HE, Beresford AP, Tarbit MH. The emerging importance of predictive ADME simulation in drug discovery. Drug Discovery Today. 2002;7(2):109\u201316.","journal-title":"Drug Discovery Today"},{"issue":"9","key":"1636_CR75","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1021\/jm0492002","volume":"48","author":"YC Martin","year":"2005","unstructured":"Martin YC. A bioavailability score. J Med Chem. 2005;48(9):3164\u201370.","journal-title":"J Med Chem"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01636-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-025-01636-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-025-01636-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:27:42Z","timestamp":1760455662000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-025-01636-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1636"],"URL":"https:\/\/doi.org\/10.1186\/s13065-025-01636-6","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was funded by the University of Jeddah, Jeddah, Saudi Arabia, under grant No. (UJ-23-DR-183). Therefore, the authors thank the University of Jeddah for its technical and financial support.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}